Penny stock under Rs 15: This micro-cap company with m-cap of less than Rs 20 crore bags new export order worth Rs 136 crore from Marlexx Pharma Inc!
The stock has a PE of 13x whereas the industry PE is 52.8x and it is trading at 0.73 times its book value of Rs 18.3.
EVOQ Remedies Ltd informed that the company has received an export order of Rs 136 crore from Marlexx Pharma Inc. to deliver high-quality pharmaceutical products which marks a significant step forward in our business growth.
Details of the products
- Metformin API
- Tramadol Hydrochloride API
- Lisinopril API Powder
- Omeprazole Powder API
- Cef0xitin Sodium Sterile
- Colistimethate Sodium Sterile
- Meropenem Sterile
- Pipracillin Sodium Sterile
Today, one of the Top Losers on BSE, shares of EVOQ Remedies Ltd plunged 16.02 per cent to Rs 13 per share with an intraday high of Rs 14.35 and an intraday low of Rs 12.51. The stock’s 52-week high is Rs 19.44 and its 52-week low is Rs 10.50.
The company has a market cap of Rs 17.68 crore. The stock has a PE of 13x whereas the industry PE is 52.8x and it is trading at 0.73 times its book value of Rs 18.3. The company reported positive numbers in its half-yearly results and annual results. According to the shareholding pattern, the promoters own 73.53 per cent stake and the rest 26.47 per cent is owned by the public as of September 2023.
Established in 2010, EVOQ Remedies Ltd. goes beyond simple pharmaceutical formulation trading, engaging in marketing, distribution, and active ingredient acquisition across pharmaceuticals, nutraceuticals, Ayurveda, and herbal products.
Disclaimer: The article is for informational purposes only and not investment advice.
DSIJ’s ‘Micro Marvel' service recommends micro-cap stocks with the potential to grow multifold in long run. If this interests you, do download the service details here.